Skip to main content
. 2024 Jan 14;9(2):486–507. doi: 10.1016/j.ncrna.2024.01.005

Table 1.

Reciprocal relationship between PI3K/AKT signaling pathway and ncRNAs in DM and its related complications.

Non-coding RNAs Name Expression levels Interaction with target molecules Associated complication Study samples Effect on PI3K/Akt pathways Refs.
MiRNAs miR-27a Upregulated Directly target PPAR-γ mouse model/3T3-L1 Inhibit PI3K/Akt pathways [54]
miR-351 Downregulated Directly target FLOT2 GDM GDM mice Inhibit PI3K/Akt pathways [56]
miR-26b Upregulated Indirectly target PI3K/Akt signaling pathway GDM GDM mice Inhibit PI3K/Akt pathways [103]
miR-125a-5p Downregulated Directly target STAT3 C57BL/6 mice Activate PI3K/Akt pathways [60]
miR-21 Upregulated Directly target PTEN DR DR models/RVECs Activate PI3K/Akt pathways [61]
Downregulated Indirectly regulated by PI3K/Akt C57BL/6/Islet cell PI3K/Akt pathways induce miR-21 [62]
miR-130b Downregulated Directly target PTEN DE PC12/hippocampal cells/Male Wistar rats Activate PI3K/Akt pathways [64]
miR-195 Upregulated Directly target Mfn2 C57BL/6J mice/palmitate-stimulated Min6 cells Inhibit PI3K/Akt pathways [65]
Upregulated Directly target PFKFB4 HCC cell lines/HCC tumor Inhibit PI3K/Akt pathways [104]
miR-7 Downregulated Directly target HOXB3 DR ARPE-19 cell line Inhibit PI3K/Akt pathways [67]
Downregulated Directly target IRS-1 DR diabetic rat model/ECs and RPs cells Inhibit PI3K/Akt pathways [68]
Downregulated Directly target IRS-2 DR mice model of DR/ECs and RPs cells Inhibit PI3K/Akt pathways [105]
miR-363-3p Downregulated Indirectly target FOXO1 insulin resistance C57BL/6J mice/HepG2 cells Activate PI3K/Akt pathways [106]
miR-19a Upregulated Directly target PTEN DR DR rat model Inhibit PI3K/Akt pathways [71]
miR-122 Upregulated Indirectly target PI3K/Akt INS-1 Inhibit PI3K/Akt pathways [107]
miR-20b-5p Upregulated Directly target THBS1 DR DR model Inhibit PI3K/Akt pathways [108]
miR-30c Downregulated Directly target ROCK2 DN Human DN tissue/HK-2 cells Inhibit PI3K/Akt pathways [74]
miR-199a-3p Downregulated Directly target FGF7 DR DR rat model//ECs and RPs cells Inhibit PI3K/Akt pathways [75]
Downregulated Directly target VEGF DR hRMECs and ARPE-19 cell Inhibit PI3K/Akt pathways [76]
Downregulated Indirectly target PI3K/Akt Peripheral blood samples/HUVECs Activate PI3K/Akt pathways [77]
miR-720 Upregulated Directly target Rab35 MIN6 cells/ Activate PI3K/Akt pathways [78]
miR-139-5p Upregulated Directly target PICK1 Min6 cells/db/db mice Inhibit PI3K/Akt pathways [79]
miR-24 Downregulated Indirectly target PI3K/Akt CAD diabetic rats/VSMCs Inhibit PI3K/Akt pathways [80]
miR-183 Upregulated Directly target BTG1 DR DR rat model Activate PI3K/Akt pathways [81]
miR-203 Downregulated Directly target PIK3CA DCM DCM mouse model Inhibit PI3K/Akt pathways [82]
miR-153 Downregulated Directly target PAQR3 DN MCs/renal tissue from DN Inhibit PI3K/Akt pathways [84]
miR-23b Downregulated Directly target HMGA2 DN db/db mice/HK-2 cells Inhibit PI3K/Akt pathways [85]
miR-126 Downregulated Directly target IRS1 DR DR rat model/ECs and RPs cells Inhibit PI3K/Akt pathways [86]
Downregulated Indirectly target PI3K/Akt Min6 cells Activate PI3K/Akt pathways [87]
Downregulated Directly target VEGFA, and PK3R2 DR RF/6A cells Inhibit PI3K/Akt pathways [88]
miR-499-5p Downregulated Directly target PTEN insulin resistance db/db mice/NCTC1469 cells Activate PI3K/Akt pathways [90]
miR-873 Upregulated Directly target IGFBP2 myocardial injury/insulin resistance GDM rat model Inhibit PI3K/Akt pathways [91]
lncRNAs MEG3 Downregulated Indirectly target PI3K/Akt DR DR Rat Models/Microvascular endothelial cells from rat retina Inhibit PI3K/Akt pathways [92]
Upregulated Directly target miR-370-3p GDM HUVEC cell Inhibit PI3K/Akt pathways [109]
PVT1 Downregulated Indirectly target PI3K/Akt DPN DPN Rat Models Activate PI3K/Akt pathways [110]
Upregulated Indirectly target PI3K/Akt GDM HTR-8/SVneo cell/trophoblast cells Activate PI3K/Akt pathways [95]
SNHG16 Upregulated Directly target miR-146a, and miR-7-5p DR hRMECs Activate PI3K/Akt pathways [96]
RPL13p5 Upregulated Indirectly target PI3K/Akt GDM peripheral blood Activate PI3K/Akt pathways [111]
UCA1 Upregulated Indirectly target PI3K/Akt DN DN rat model Activate PI3K/Akt pathways [112]
HOTAIR Downregulated Indirectly target PI3K/Akt DCM Myocardial biopsy/AC16 cell Activate PI3K/Akt pathways [99]
TUG1 Downregulated Indirectly target PI3K/Akt DN DM rats/Mouse-derived mesangial cells Inhibit PI3K/Akt pathways [113]
LINC00323 Upregulated Indirectly target PI3K/Akt DN blood samples of DN patients Activate PI3K/Akt pathways [101]
HEIH Upregulated Directly target miR-939 DR ARPE-19/DR patients Activate PI3K/Akt pathways [102]